Overall, these studies underscore the intricate relationships between DPP-4, glucose regulation, obesity, and inflammation, highlighting its complexity and interactions with bone metabolism, along with its regulatory mechanisms, suggesting potential therapeutic implications [4, 32, 36]. Here, DPP4 is linked to obesity due to melanocortin 4 receptor deficiency.